All Curated Mutation Sites in HCMV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCMV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
gB
  
IE2
  
Pol
  
protease
  
UL18
  
UL27
  
UL54
  
UL56
  
UL89
  
UL97
  
US28
  

Keyword: Cytomegalovirus infections-40143348
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 40143348 A594V
UL97
UL97
Cytomegalovirus infections
D
R
View
2 40143348 A987G
UL54
UL54
Cytomegalovirus infections
D
R
View
3 40143348 C480F
UL97
UL97
Cytomegalovirus infections
D
R
View
4 40143348 C592G
UL97
UL97
Cytomegalovirus infections
D
R
View
5 40143348 C603W
UL97
UL97
Cytomegalovirus infections
D
R
View
6 40143348 D413E
UL54
UL54
Cytomegalovirus infections
D
R
View
7 40143348 F342Y
UL97
UL97
Cytomegalovirus infections
D
R
View
8 40143348 H411Y
UL97
UL97
Cytomegalovirus infections
D
R
View
9 40143348 H520Q
UL97
UL97
Cytomegalovirus infections
D
R
View
10 40143348 L501I
UL54
UL54
Cytomegalovirus infections
D
R
View
11 40143348 L595F
UL97
UL97
Cytomegalovirus infections
D
R
View
12 40143348 L595S
UL97
UL97
Cytomegalovirus infections
D
R
View
13 40143348 M460I
UL97
UL97
Cytomegalovirus infections
D
R
View
14 40143348 M460V
UL97
UL97
Cytomegalovirus infections
D
R
View
15 40143348 P522S
UL54
UL54
Cytomegalovirus infections
D
R
View
16 40143348 T409M
UL97
UL97
Cytomegalovirus infections
D
R
View
17 40143348 T503I
UL54
UL54
Cytomegalovirus infections
D
R
View
Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.